4//SEC Filing
O'Keeffe Charles B 4
Accession 0001161697-24-000026
CIK 0001369568other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:18 PM ET
Size
7.1 KB
Accession
0001161697-24-000026
Insider Transaction Report
Form 4
O'Keeffe Charles B
Director
Transactions
- Exercise/Conversion
Options to purchase common stock
2024-01-02−60,000→ 232,931 totalExercise: $1.13Exp: 2024-01-03→ Common Stock (60,000 underlying) - Exercise/Conversion
Common Stock, par value $0.001 per share
2024-01-02$1.13/sh+60,000$67,800→ 681,724 total
Footnotes (1)
- [F1]Options vested in three annual tranches beginning on January 3, 2018.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001378656
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:18 PM ET
- Size
- 7.1 KB